
Public Health Survived the Pandemic. Now It Fights Politics.
For months, Dr. Jennifer Avegno, the director of the New Orleans Health Department, has watched the threats come closer: Louisiana led the United States as seasonal flu cases surged to their highest rate in 15 years, and had the nation's first death from bird flu. Then came a deadly measles outbreak in neighboring Texas. The number of Louisiana schoolchildren with exemptions to vaccine requirements doubled in a year.
During the Covid pandemic, Dr. Avegno worked with state officials to tame high infection rates and promote vaccines. But after taking office last year, Gov. Jeff Landry began carrying out a promise to remake public health after the state's Covid response, which he thought was a disaster.
Mr. Landry, a Republican, created a position for a state surgeon general, appointing Dr. Ralph Abraham, a former congressman who had railed against the state's 'tyrannical' Covid response and argued that the real risk was not the virus itself but the vaccines against it.
So it was not entirely a surprise when Dr. Abraham announced last month that Louisiana would 'no longer promote mass vaccination,' calling efforts to do so during Covid 'an offense against personal autonomy that would take years to overcome.'
To Dr. Avegno, it was a blunt reminder of how the political aftereffects of the pandemic have left her field worse prepared in many ways to fight the next one.
'We're in a very different world right now,' she said. 'We are now prepared to throw the baby out with the bath water and leave ourselves incredibly vulnerable.'
Local public health officials like Dr. Avegno are the front line for responding to any disease outbreak. Five years after the pandemic began, many say that the entrenched politicization of Covid has left them with fewer tools to respond and fresh challenges:
Janet Hamilton, the executive director of the Council of State and Territorial Epidemiologists, said that mistrust in public health has made it harder to respond early. She compared fighting outbreaks to battling a blaze, and said lower vaccination rates are providing a path for them to spread.
'The line of gas that's there, that the fire can travel along, exists in ways that it did not exist in 2019,' she said.
Local health officials no longer need police protection or to sleep away from home as some did when the public was revolting against mask mandates and other Covid restrictions. In interviews over the last month with two dozen local and state health officials, many acknowledged that public health authorities had made mistakes as they tried to respond to a novel, constantly changing virus — the first outbreak in more than a century that resulted in widespread lockdowns. They say they have learned from those missteps.
Many ruled out future lockdowns, closures or other blanket mitigation strategies.
'That ship has completely sailed,' said Dr. Anne Zink, who was Alaska's chief medical officer during the pandemic. 'And maybe for the best.'
Instead, she and others said, public health agencies need to be 'really nimble' and respond with targeted interventions like tracking down individuals with an infectious disease, identifying their contacts and working to reduce the risk of further spread. This requires sufficient resources and detailed, up-to-date information about the threat.
Yet Dr. Sanmi Areola, director of the Metro Public Health Department in Nashville, worries that laws passed in response to the Covid-19 pandemic are so broad that they would limit the ability to fight a fast-moving threat. Tennessee, like several other states, now has a law stating that only the governor can order infected patients to isolate or exposed people to quarantine during a pandemic. Several states this year have proposed banning mRNA vaccines, the kind used against Covid, based on false assertions that they change recipients' DNA.
Absent the powers public health officials once had, Dr. Areola said, 'Public perception, right or wrong, is a very important piece. We have to invest in crafting messages and explaining the benefits.'
The biggest lesson, many health officials said, is the importance of clear communication.
Many have invested in new outreach campaigns. Erin Ourada, a public health administrator in North Dakota, said each of her agency's roughly 30 staff members travel to at least one community meeting each month to share updates about the department's work.
In Clackamas County, Ore., the health department tapped trusted community members to speak to specific groups, including Hispanic and Eastern European immigrants. As Oregon battled its largest measles outbreak in decades last year, they fanned out to address skepticism about vaccines.
Still, Dr. Sarah Present, the county's health officer, worries about what she described as the moral injury to the field — the toll taken by the angry public confrontations, the threats, the friends who shied away. Like others, she has stopped telling strangers what she does, after people she met socially took it as an opportunity to debate vaccinations.
'I think that people's exhaustion and the burnout in public health also makes us a little bit less prepared,' she said.
In Pima County, Ariz., which includes Tucson, Dr. Theresa Cullen set up the largest free Covid-19 testing program in the state and established mobile vaccination clinics to serve rural residents. But after Gov. Katie Hobbs nominated her to lead the state's health department, she quickly became what one friend called a 'voodoo doll' for public health.
At her confirmation hearing in 2023, one state senator blamed her for the depression and suicides of students during school closures; one person testified that Dr. Cullen's agency had 'terrorized' local businesses.
'I was taken aback by the ferociousness,' Dr. Cullen said in an interview. 'Because I know why I wanted to do that job, and it was service.'
The governor withdrew her nomination, and Dr. Cullen stayed in Pima County. Others walked away from the stress. With them went a lot of experience: One study found that nearly half of all public health employees who were working at state and local agencies in 2017 had left by 2021.
'People who had been there for 20 years, people who have seen measles before or done a measles outbreak, those who worked through Ebola in the past, a lot of them are gone,' Dr. Zink said.
At the same time, public health challenges are increasing. Extreme heat and disasters like hurricanes and wildfires are demanding responses from local departments that are also confronting outbreaks of measles, whooping cough, syphilis, H.I.V. and TB.
The federal government sent billions of dollars in pandemic funding to state and local health departments. But that emergency money has all but dried up, leaving local departments with fewer resources to shore up staff, trace new viruses and expand vaccine campaigns.
'People don't question the police and fire budgets — when you dial 911, you're going to have a police officer come,' said Renae Moch, a public health officer in North Dakota. 'Public health is kind of the same, but we don't get the same respect. We're here 24/7 too. Why do we have to keep showing our worth?'
Dr. Eric Chow, the interim health officer for Seattle's health department, said the spread of bird flu from farms to humans is a top concern, as Washington has had more cases than most states. Though a vaccine is available, disseminating it would be difficult.
'To be able to stand up the access points, get the information out to people,' he said, 'we're going to require much more federal support.'
When the pandemic started, the C.D.C. was not sharing data on the outbreak. It was left to universities and private entities to create public dashboards.
In 2023, the C.D.C. created the Center for Forecasting and Outbreak Analytics, a network of centers that collect and distribute data and information. But there are fears that it will be the victim of budget cuts.
With the Trump administration reining in communications from health agencies, 'there's this massive gap in communication happening — within the C.D.C., between the C.D.C. and states, between the C.D.C. and academic research partners,' said Dr. Lauren Gardner, an infectious disease expert at Johns Hopkins. In January 2020, Dr. Gardner created an interactive Covid dashboard that members of the public and health officials around the world quickly came to rely on.
Local health departments 'all have to be networked into something that's overseeing things at a higher level — that's the C.D.C.,' she said. And given the uncertainty around the agency, she added, 'the C.D.C. is going to struggle to fulfill that role right now.'
Local officials say that without coordination with the federal government, it will be hard to act on the lessons they've learned from Covid.
'Public health credibility quickly went out the window when the public could see that we sometimes weren't in the loop either,' said Ms. Ourada, in North Dakota. 'That's kind of what has brought us to where we are today, where we aren't trusted members of the community anymore.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul
Former White House COVID-19 response coordinator Ashish Jha, who served under former President Biden, criticized the decision by Health and Human Services Secretary Robert F. Kennedy Jr. to fire all 17 experts on the U.S. Centers for Disease Control and Prevention's (CDC) vaccine panel. Kennedy announced the decision in an op-ed for The Wall Street Journal on Monday, saying, 'A clean sweep is needed to re-establish public confidence in vaccine science.' But in an interview with CNN's Wolf Blitzer, Jha pushed back against Kennedy's reasoning. 'Look, what he said in his op-ed was a series of nonsense about a group of individuals, experts …who shape what vaccines, if any, are going to be available to the American people,' Jha said in the interview. 'So obviously this is very concerning,' he continued. 'We'll have to see who he appoints next. But this is a step in the wrong direction.' Jha said he is concerned about what the move foretells about the secretary's agenda on vaccines. Jha pointed to what he characterized as a lackluster response from the secretary to 'the worst measles outbreak of the last 25 years.' He also expressed concern regarding Kennedy's raising questions about vaccines causing autism, which Jha dismissed and said was 'settled science.' 'Then you put this in the middle of all of that,' Jha said, referring to the vaccine panel sweep, 'and what you have is a pretty clear picture that what Secretary Kennedy is trying to do is make sure that vaccines are not readily available to Americans, not just for kids, for the elderly.' 'He could go pretty far with this move, and I really am worried about where we're headed,' Jha continued. He said he's particularly concerned about the effect Kennedy's move will have on kids and whether they will continue having access to certain vaccines in the future. 'Kids rely on vaccines. I'm worried about whether the next generation of kids are going to have access to polio vaccines and measles vaccines. That's where we're heading. That's what we have to push back against.' Kennedy said in his op-ed that he was removing every member of the panel to give the Trump administration an opportunity to appoint its own members. Kennedy has long accused members of the Advisory Committee on Immunization Practices of having conflicts of interest, sparking concern among vaccine advocates that he would seek to install members who are far more skeptical of approving new vaccines. But Jha pushed back against criticism that the panel was all Biden-appointed experts, saying, 'When the Biden administration came in, almost all of the appointees had come from the first Trump administration.' 'That was fine because they were good people,' he said. 'They were experts. Right now, it's the same thing. The people he is firing are experts — like a nurse in Illinois who spent her entire career getting kids vaccinated, cancer doctors from Memorial Sloan Kettering — like these are really good people.' 'And generally, CDC has not worried about when were they appointed. The question is, are they good and are they conflict free.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
5 hours ago
- Yahoo
NIH Director Struggles To Defend His Own Plan To Slash $18 Billion In Medical Research
WASHINGTON ― National Institutes of Health director Jayanta Bhattacharya got a cool reception from Democratic and Republican senators on Tuesday as he defended his agency's budget request for 2026, which would slash billions in cutting-edge biomedical research on cancer, Alzheimer's disease, diabetes and other health conditions. NIH is considered the crown jewel of American science and the global leader in biomedical research and innovation. Senators in both parties are proud of its success and of their own roles in boosting its funding over the years in support of medical breakthroughs. So Bhattacharya had to know his budget request would land with a thud as he presented it to a Senate appropriations subcommittee. He kept trying to square two things that didn't make sense: that Trump is committed to preserving America's role as the leader in biomedical research, and that his proposed $18 billion in cuts to the agency next year ― or 40% of its entire budget ― won't hamper that. Senators didn't buy it. At times, Bhattacharya didn't seem to want to defend it, either. Sen. Susan Collins (R-Maine), who chairs the full Senate Appropriations Committee, called the administration's proposed cuts to NIH 'so disturbing.' 'It would undo years of congressional investment in NIH, and it would delay or stop effective treatments and cures from being developed for diseases,' Collins said. 'We also risk falling behind China and other countries that are increasing their investment in biomedical research.' In particular, she asked why the administration is calling for the cutting of funding by 40% for the National Institutes of Aging, which funds most Alzheimer's research, when it's been successfully developing breakthrough drugs and blood tests. Bhattacharya, without defending his own proposed cuts, said 'the intention' of the Trump administration is to lead the world in biomedical research, suggesting Congress could make a counteroffer and potentially propose more spending. 'The budget is a collaborative effort between the Congress and the administration,' he said. Collins simply replied, 'We look forward to working with you to remedy these problems and the deficiencies in the budget.' Sen. Patty Murray (D-Wash.), the top Democrat on the appropriations panel, ripped the administration's 'catastrophic' cuts to NIH to date. She said Trump has so far forced out nearly 5,000 employees, prevented nearly $3 billion in grants from being awarded, and terminated nearly 2,500 grants totaling almost $5 billion for life-saving research. 'The Trump administration is already systematically dismantling the American biomedical research enterprise that is the envy of the world, throwing away billions in economic activity in every one of our states,' Murray fumed. 'This budget proposal would effectively forfeit our leadership in research innovation and competitiveness to China.' She tangled with Bhattacharya over one of dozens of clinical trials that have been halted due to frozen NIH funds: a 23-year research effort to develop an HIV vaccine. Scientists there are on 'the cusp of a functional cure for HIV,' she said, and now 6,000 people in that trial have been cut off from treatment. Bhattacharya jumped in to say he is 'absolutely committed' to supporting research on HIV. 'But you did terminate the HIV research at Fred Hutch that, again, was on the cusp of a treatment for 6,000 patients nationwide,' Murray replied, referring to the Fred Hutchinson Cancer Research Center in Seattle. 'You did do that,' she said, as they talked over each other. 'I'd have to get back to you on that,' said Bhattacharya. 'You did do that,' she repeated. After more back and forth, the NIH director said again, 'The budget request is a work of negotiation between Congress and the administration.' Minutes later, he said it yet again, as Murray pressed for details on how many fewer clinical trials there would be next year because of the Trump administration's proposed cuts. 'I'll say this,' Bhattacharya declared. 'The budget itself is a negotiation between Congress and the administration.' He said it several other times, too. In fact, it became clear this was the NIH director's go-to line for defending his own devastating budget request. It simultaneously allowed him to stand by his bosses ― Trump, and Health and Human Services Secretary Robert F. Kennedy Jr. ― while not exactly arguing in support of its specific cuts. 'President Trump has committed that the U.S. be the leading nation in biomedicine in the 21st century,' he said at one point. 'I entirely support that goal.' 'Well, I do too, but it's hard to understand how we're going to get there when the budget slashes funding,' replied Sen. Jeanne Shaheen (D-N.H.). 'Particularly in critical areas of research where our most critical competitor, the Chinese, are increasing funding in those areas and we're slashing the budgets.' Bhattacharya didn't respond. It's possible he may not have agreed with some of his own budget's cuts. Bhattacharya certainly had a hand in crafting his agency's budget, but so did other officials at the White House and the Department of Health and Human Services. Before becoming NIH director in April, Bhattacharya was a professor of medicine, economics and health research policy at Stanford University. He knows how vital and highly esteemed NIH is, worldwide. Why not put it on Congress to save it? 'You say this is a collaborative effort, and you're absolutely right, and I encourage Congress to exert its authorities,' said Sen. Jerry Moran (R-Kansas). 'If Congress were to provide additional dollars above and beyond the president's budget request, how would we as a committee and how would you as NIH recommend for us to prioritize that spending?' Bhattacharya said he's focused on the 'real health needs' of Americans, like diabetes and cancer, and on the 'need to think big' for advancing science. 'Again, the budget, it's a collaborative effort,' he said. 'But I think it's going to be important that we address the real problems in science and the real needs of the American people with whatever budget comes out. That's my job.' Moran redirected Bhattacharya back to the need for more funding at NIH. 'I assume that means we need more resources,' said the Republican senator. 'And that you would put them to good use. Is that accurate?' 'That's my job,' replied the NIH director.
Yahoo
7 hours ago
- Yahoo
UAMS chancellor stepping down after 7 years, returning to faculty
UAMS Chancellor Cam Patterson announces a new $31.7 million grant from the National Institutes of Health on July 10, 2024. (Mary Hennigan/Arkansas Advocate) The leader of Arkansas' largest healthcare system will step down after seven years for personal and medical reasons, the University of Arkansas for Medical Sciences announced Tuesday in a news release. Dr. Cam Patterson became the university's chancellor in June 2018. By giving up his position as chancellor and as UAMS Health CEO, he will return to being a faculty member in the university's cardiology department. Patterson 'is facing medical and personal issues that require more attention than he can give them while serving in the chancellor's position,' according to UAMS' news release. 'The work our team has done at UAMS over the last seven-plus years has been the high point of my career,' Patterson said in the release. 'We have a lot to be proud of and I've been the luckiest guy to be a part of it. I am excited about the opportunity to return to the faculty and engage more deeply in the academic and clinical missions at our institution.' UAMS System President Jay Silveria praised Patterson's leadership tenure in the release. 'Leading UAMS is a demanding task, and I appreciate Dr. Patterson's need to do what he feels is best for himself and his family and for the long-term success of the university,' Silveria said. 'His contributions to UAMS came through unusually restrictive times, and he should be celebrated for his efforts to push the institution forward while navigating a challenging environment.' Patterson 'oversaw both challenges and improvement in the university's economic outlook, despite the myriad issues presented by the COVID-19 pandemic and other unforeseen variables,' the release states. One such challenge was a conflict between state and federal mandates regarding COVID-19 vaccinations. The federal Centers for Medicare and Medicaid Services issued a mandate in November 2021 for health workers to be fully vaccinated or receive exemptions, with noncompliant facilities at risk of losing federal funding. The rule directly conflicted with a 2021 Arkansas law that said COVID-19 vaccination 'shall not be a condition of education, employment, entry, or services from the state or a state agency or entity' unless lawmakers approved an exception. Patterson sought an exemption and defended this decision before a legislative committee. Silveria will name an interim UAMS chancellor 'in the coming weeks' and start a national search for Patterson's permanent successor, the news release states. SUPPORT: YOU MAKE OUR WORK POSSIBLE